Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://www.nejm.org/doi/full/10.1056/NEJMoa2303974
0
0
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer | NEJM - nejm.org
10/18/23 at 9:01pm
Organization
nejm.org
Author
nejm.org
Details
12 words
Summarize
Health
Xtandi
Biochemically Recurrent Prostate Cancer
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...